Form 4 for AORT ARTIVION, INC.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-02 · accession 0001628280-26-013690 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-03-02 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $38.02 | -1,513 | 40.4K | -4% | -$57.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 1,513 | $38.02 | 40,408 | D | — | — | (F1) These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |